companydata.dkcompanydata.dk

PEAK BIOTECH A/S: Financial statements 2017

CVR: 28892152

Source: annual report 2017, Danish Business Authority

01/07/2016 – 30/06/2017

PEAK BIOTECH A/S (CVR 28892152) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 7,692,103 and a net result of DKK 4,567,886 compared with DKK 3,453,137 the year before. That is an increase of 24% compared with the year before. Equity in the 2017 report amounted to DKK 8,462,776. The solvency ratio was 56.5%. The company had 3 employees in the financial year.

Gross Profit
DKK 7,692,103
Profit/Loss
DKK 4,567,886
Equity
DKK 8,462,776
Total Assets
DKK 14,978,956
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-7.7 mio.4.6 mio.8.5 mio.3
2016-6.2 mio.3.5 mio.6.9 mio.-
2015-1.3 mio.-325 t.3.4 mio.-
2014-1.9 mio.369 t.4.1 mio.-
2013-2.1 mio.434 t.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PEAK BIOTECH A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About PEAK BIOTECH A/S

PEAK BIOTECH A/S is a Danish company of the type Aktieselskab based in Kvistgård, founded in 2005. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Kim Gejl Vind. The board consists of Jens Ulrik Damgaard (chair), Jacob Nøhr and Kim Gejl Vind. The company is owned by BIOTECH HOLDING ApS and PEAK HOLDING ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 29,437,632 and a net result of DKK 21,861,113 compared with DKK 16,506,232 the year before. Equity in the 2025 report amounted to DKK 43,994,380.

Source: annual report 2025, Danish Business Authority